TrianglePUBLICATIONS · 39914418
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2025 Feb
- First author
- Wang M
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2025 May;26(5):e238. doi: 10.1016/S1470-2045(25)00210-4.
- note
- Source null
- related pmid
- 40318652
- relationship
- Erratum in
Authors and identifiers
- name
- Wang M
- type
- Author
- name
- Jurczak W
- type
- Author
- name
- Trneny M
- type
- Author
- name
- Belada D
- type
- Author
- name
- Wrobel T
- type
- Author
- name
- Ghosh N
- type
- Author
- name
- Keating MM
- type
- Author
- name
- van Meerten T
- type
- Author
- name
- Alvarez RF
- type
- Author
- name
- von Keudell G
- type
- Author
- name
- Thieblemont C
- type
- Author
- name
- Peyrade F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wang M
- type
- Author
- name
- Jurczak W
- type
- Author
- name
- Trneny M
- type
- Author
- name
- Belada D
- type
- Author
- name
- Wrobel T
- type
- Author
- name
- Ghosh N
- type
- Author
- name
- Keating MM
- type
- Author
- name
- van Meerten T
- type
- Author
- name
- Alvarez RF
- type
- Author
- name
- von Keudell G
- type
- Author
- name
- Thieblemont C
- type
- Author
- name
- Peyrade F
- type
- Author
- bibliography ids
- nci-bib-e323d10a7437db7445e2f68e
- book metadata
- content sha256
- 9a1eeedb92f06f900adfa018f6dbac5fd5913438633306a3eec86626d5c70919
- document type
- citation
- dois
- 10.1016/S1470-2045(24)00682-X
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:39914418
- immutable id
- pubmed:39914418@9a1eeedb92f06f900adfa018f6dbac5fd5913438633306a3eec86626d5c70919
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 2
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 200-213
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2025 May;26(5):e238. doi: 10.1016/S1470-2045(25)00210-4.
- note
- Source null
- related pmid
- 40318652
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 39914418
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- 2ea2f09f1869b804af7d259cf71c8132519fb723c34d4287618fe650a45380a7
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2025 Feb
- precision
- month
- year
- 2025
- publication types
- Journal Article
- Randomized Controlled Trial
- Multicenter Study
- Clinical Trial, Phase III
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Preserved source evidence · Not medical advice